On October 30, 2024, the price target was updated following the announcement of the extension of short-time work at the Geratal site. ResearchHub continues to issue a Buy recommendation for the Geratherm share, with a price target of EUR 7.00. The market situation remains challenging, which was reflected in a 47% decline in sales in the first half of 2024 compared to the previous year.

Research Hub gives investors free access to updates of Geratherm Medical's digital coverage.

Alternatively, you can find the update as a PDF file here.